These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 3052008)

  • 1. Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmias.
    Kuchar DL; Garan H; Ruskin JN
    Am J Cardiol; 1988 Oct; 62(12):39H-45H. PubMed ID: 3052008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of the outcome of electrophysiologic study in patients with ventricular tachyarrhythmias.
    Schoenfeld MH; McGovern B; Garan H; Kelly E; Grant G; Ruskin JN
    J Am Coll Cardiol; 1985 Aug; 6(2):298-306. PubMed ID: 4019918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
    Steinbeck G; Bach P; Haberl R
    J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple monomorphic ventricular tachycardia configurations predict failure of antiarrhythmic drug therapy guided by electrophysiologic study.
    Mitrani RD; Biblo LA; Carlson MD; Gatzoylis KA; Henthorn RW; Waldo AL
    J Am Coll Cardiol; 1993 Oct; 22(4):1117-22. PubMed ID: 8409050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing.
    Rae AP; Kay HR; Horowitz LN; Spielman SR; Greenspan AM
    J Am Coll Cardiol; 1988 Jul; 12(1):131-9. PubMed ID: 3379198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
    Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W
    Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term reproducibility of responses to programmed cardiac stimulation in spontaneous ventricular tachyarrhythmias.
    Schoenfeld MH; McGovern B; Garan H; Ruskin JN
    Am J Cardiol; 1984 Sep; 54(6):564-8. PubMed ID: 6475774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: complete versus partial suppression of inducible arrhythmias.
    Borggrefe M; Trampisch HJ; Breithardt G
    J Am Coll Cardiol; 1988 Jul; 12(1):140-9. PubMed ID: 3379199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of programmed stimulation in assessing vulnerability to ventricular arrhythmias.
    Horowitz LN; Spielman SR; Greenspan AM; Josephson ME
    Am Heart J; 1982 Apr; 103(4 Pt 2):604-10. PubMed ID: 7064803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of electropharmacologic testing in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmias.
    Liem LB; Swerdlow CD
    Am J Cardiol; 1988 Sep; 62(9):611-6. PubMed ID: 3414554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of ventricular tachycardia suppression by antiarrhythmic drug therapy during serial electrophysiologic testing in coronary artery disease.
    Garan H; Stavens CS; McGovern B; Kelly E; Ruskin JN
    Am J Cardiol; 1986 Nov; 58(10):977-80. PubMed ID: 3776854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed ventricular stimulation in predicting vulnerability to ventricular arrhythmias and their response to antiarrhythmic therapy.
    Mason JW; Swerdlow CD; Winkle RA; Griffin JC; Ross DL; Keefe DL; Clusin WT
    Am Heart J; 1982 Apr; 103(4 Pt 2):633-9. PubMed ID: 7064805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies.
    Rae AP; Greenspan AM; Spielman SR; Sokoloff NM; Webb CR; Kay HR; Horowitz LN
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1494-9. PubMed ID: 3890509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; DiCarlo L; Gold MR; Greer GS; Prystowsky EN; O'Toole MF; Tang A; Fisher JD; Coromilas J; Talajic M; Hafley G
    N Engl J Med; 2000 Jun; 342(26):1937-45. PubMed ID: 10874061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: results, optimal stimulation protocol and cost-effective screening.
    Bourke JP; Richards DA; Ross DL; Wallace EM; McGuire MA; Uther JB
    J Am Coll Cardiol; 1991 Sep; 18(3):780-8. PubMed ID: 1907984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of electrophysiologic testing in patients with nonsustained ventricular tachycardia: prognostic and therapeutic implications.
    Klein RC; Machell C
    J Am Coll Cardiol; 1989 Jul; 14(1):155-61; discussion 162-3. PubMed ID: 2738260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic drug testing in patients with malignant ventricular arrhythmias: importance of stimulation at more than one ventricular site.
    Morady F; Hess D; Scheinman MM
    Am J Cardiol; 1982 Nov; 50(5):1055-60. PubMed ID: 7137032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Waxman HL; Buxton AE; Sadowski LM; Josephson ME
    Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of nonsustained ventricular tachycardia as a guide to antiarrhythmic drug therapy in patients with malignant ventricular arrhythmia.
    Podrid PJ; Schoeneberger A; Lown B; Lampert S; Matos J; Porterfield J; Raeder E; Corrigan E
    Am Heart J; 1983 Feb; 105(2):181-8. PubMed ID: 6823797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical electrophysiology of ventricular tachycardia.
    Prystowsky EN; Heger JJ; Lloyd EA; Zipes DP
    Cardiol Clin; 1983 May; 1(2):253-73. PubMed ID: 6544638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.